Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Print ads will break in July for Lamisil AT Spray Pump and Solution Dropper (terbinafine hydrochloride 1%). The line extensions shipped May 19 (1"The Tan Sheet" March 27, p. 10). TV spots broke the week of June 18, and an FSI advertising "The best way to cure athlete's foot now in a targeted spray" dropped June 25. A third new product, Odor Guard deodorant foot powder, "From the makers of Lamisil AT," will be supported with dedicated promotions and advertising in health clubs. The spray pump and dropper will each retail for $9.99, the powder for $4.99

You may also be interested in...

Lamisil AT Spray Pump, Solution Dropper Line Extensions Launching June 1

Novartis Lamisil AT Spray Pump and Solution Dropper, both terbinafine hydrochloride solution 1%, are launching June 1, "just in time for the peak summer athlete's foot season," the firm said. FDA approved the Rx-to-OTC switch March 17. Novartis filed the NDA (21-124) for the topical solution with the agency May 14, 1999.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts